首页 | 本学科首页   官方微博 | 高级检索  
检索        

华蟾素微球合并多柔比星和顺铂肝动脉化学栓塞治疗肝癌
引用本文:范健,郭金和,何仕成,滕皋军,翁帼英.华蟾素微球合并多柔比星和顺铂肝动脉化学栓塞治疗肝癌[J].中国新药与临床杂志,2001,20(1):30-32.
作者姓名:范健  郭金和  何仕成  滕皋军  翁帼英
作者单位:1. 南京铁道医学院附属医院江苏南京 210009
2. 南京药物研究所江苏南京 210009
摘    要:目的 :观察华蟾素微球合并多柔比星、顺铂肝动脉化学栓塞治疗肝癌的临床效果。方法 :采用Seldinger方法超选至肿瘤血管 ,注入化疗药物和华蟾素微球 10 0~ 50 0mg ,治疗肝癌 4 3例。结果 :4 1例病人肿瘤部分缓解 14% ,轻微缓解 54% ,甲胎蛋白 (AFP)水平明显降低。 0 .5,1和 2a生存率分别为 95% ,51%和 2 9%。结论 :华蟾素微球合并多柔比星、顺铂是一种治疗肝癌较好的肝动脉化学栓塞剂

关 键 词:肝肿瘤  华蟾素  微球体  治疗性栓塞  多剂联用抗肿瘤药
文章编号:1007-7669(2001)01-0030-03

Artreial chemoembolization of liver carcinoma with sinobufagin microsphe re combination doxorubicin and cisplatin
Abstract:AIM: To study the clinical therapeutic effects of the sinobufagin microsphere combination doxorubicin and cisplatin in artreial chemoembolization of liver carcinoma. METHODS: Transcatheter arterial chemoembolization of tumor vessels was performed in 43 patients using Seldinger's method. The liver arterioles were occlued by using sinobufagin microspheres 100-500 mg. RESULTS: There were 14% partial relief and 54% minor relief in 41 patiets. The serum AFP level apparently decreased. The cumulative survival rate was 95% at 6 mo, 51% at 1 a and 29% at 2 a. CONCLUSION: The sinobufagin microspheres combination doxorubicin and cisplatin is a better chemoembolizaion agents for liver cancer.
Keywords:liver neoplasms  sinobufagin  microspheres  enbolization  therapeutic  combined antineoplastic age?
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号